Sort
16,300 grants matching “fatty liver disease”
Xenobiotic-responsive hepatic long non-coding RNAs
$471,971David J Waxman · Boston University (Charles River Campus) · R01 · FY2022 · ES
Xenobiotic-responsive hepatic long non-coding RNAs
$471,971David J Waxman · Boston University (Charles River Campus) · R01 · FY2024 · ES
Xenobiotic-responsive hepatic long non-coding RNAs
$471,971David J Waxman · Boston University (Charles River Campus) · R01 · FY2020 · ES
Xenobiotic-responsive hepatic long non-coding RNAs
$471,971David J Waxman · Boston University (Charles River Campus) · R01 · FY2021 · ES
An NADH-ChREBP axis in fatty liver disease and dyslipidemia
$471,860Russell Paul Goodman · Massachusetts General Hospital · R01 · FY2025 · DK
Regulation of glycogen in health and disease
$471,833Alan R. Saltiel · University Of California, San Diego · R01 · FY2024 · DK
Environmental Liver Disease
$471,710Matthew C Cave · University Of Louisville · R35 · FY2023 · ES
Role of the renal organic anion transporter OAT1 in metabolism and physiology
$471,623Sanjay K Nigam · University Of California, San Diego · R01 · FY2019 · GM
APJ receptor agonism for metabolic syndrome
$471,450Rangan Maitra · Research Triangle Institute · R01 · FY2017 · DK
A poly-omic study of the molecular mechanisms underlying maternal diet interventions for offspring obesity and NAFLD
$471,414Linglin Xie · Texas A&M Agrilife Research · R01 · FY2020 · DK
Contributions of Hepatic and Intestinal Pathways to Cholesterol Excretion
$471,281Gregory A Graf · University Of Kentucky · R01 · FY2024 · DK
The Saint Louis University Component of the NASH Clinical Research Network
$471,172Brent A Neuschwander-Tetri · Saint Louis University · U01 · FY2010 · DK
Role of Hypoxia-inducible factor-2a in L-cell nutrient sensing and metabolic homeostasis
$471,136Sadeesh Kumar Ramakrishnan · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK
TECHNIQUE DEVELOPMENT FOR HYPERPOLARIZED C-13 MR STUDIES
$471,132Daniel B Vigneron · University Of California, San Francisco · R01 · FY2007 · EB
Anti-inflammatory functions for non-transcriptional IRF3
$471,039Saurabh Chattopadhyay · University Of Toledo Health Sci Campus · R01 · FY2021 · AI
Stratification of Non-alcoholic Fatty Liver Disease using the SAFE Score
$471,006W. Ray Kim · Stanford University · R01 · FY2020 · DK
Defects in junctional adhesion molecule-A and Intestinal Permeability: Identification of Novel Mechanisms Driving Non-Alcoholic Steatohepatitis
$470,998Frank A. Anania · Emory University · R01 · FY2017 · DK
Defects in junctional adhesion molecule-A and Intestinal Permeability: Identification of Novel Mechanisms Driving Non-Alcoholic Steatohepatitis
$470,998Mark J. Czaja · Emory University · R01 · FY2019 · DK
Defects in junctional adhesion molecule-A and Intestinal Permeability: Identification of Novel Mechanisms Driving Non-Alcoholic Steatohepatitis
$470,998Mark J. Czaja · Emory University · R01 · FY2020 · DK
Defects in junctional adhesion molecule-A and Intestinal Permeability: Identification of Novel Mechanisms Driving Non-Alcoholic Steatohepatitis
$470,998Mark J. Czaja · Emory University · R01 · FY2018 · DK
Advanced C-arm imaging platform for histotripsy treatment of liver tumors
$470,953Paul F Laeseke · University Of Wisconsin-Madison · R01 · FY2024 · EB
Deciphering the physiology of neonatal beige adipocytes
$470,918Sadeesh Kumar Ramakrishnan · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DK
Deciphering the physiology of neonatal beige adipocytes
$470,918Sadeesh Kumar Ramakrishnan · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK
NASH Clinical Research Network
$470,848Anna Mae Elizabeth Diehl · Duke University · U01 · FY2011 · DK
Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia
$470,819Oleh Taratula · Oregon State University · R37 · FY2019 · CA